Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan

Cancer Science

Volumn 99, Issue 2, 2008, Pages 345-349

  Chang, Kung Chao ^a   Chen, Paul Chih Hsueh ^b   Jones, Dan ^c   Su, Ih Jen ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX RATIO; SOCIOECONOMICS; TAIWAN; TIME; VIRUS INFECTION;

ADULT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN;

EID: 38949142261     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00667.x     Document Type: Article

References (33)

1. Lehane DE. A seroepidemiologic study of infectious mononucleosis. The development of EB virus antibody in a military population. JAMA 1970; 212: 2240-2.
2. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981; 304: 135-40.
3. Hjalgrim H, Askling J, Rostgaard K et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003; 349: 1324-32.
4. Hesse J, Ibsen KK, Krabbe S, Uldall P. Prevalence of antibodies to Epstein-Barr virus (EBV) in childhood and adolescence in Denmark. Scand J Infect Dis 1983; 15: 335-8.
5. Sumaya CV, Henle W, Henle G, Smith MH, LeBlanc D. Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis 1975; 131: 403-8.
6. Ambinder RF, Browning PJ, Lorenzana I et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462-7.
7. Kanavaros P, Sakalidou A, Tzardi M et al. Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin's disease arising in childhood. Pathol Res Pract 1994; 190: 1026-30.
8. Weinreb M, Day PJ, Murray PG et al. Epstein-Barr virus (EBV) and Hodgkin's disease in children: Incidence of EBV latent membrane protein in malignant cells. J Pathol 1992; 168: 365-9.
9. Chang KC, Khen NT, Jones D, Su IJ. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol 2005; 36: 747-55.
10. Quintanilla-Martinez L, Gamboa-Domnquez A, Gamez-Ledesma I, Angeles-Angeles A, Mohar A. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico. Mod Pathol 1995; 8: 675-9.
11. Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the 'two-disease hypothesis'. Cancer Treat Rep 1982; 66: 689-95.
12. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966; 26: 1189-201.
13. Correa P, O'Conor GT. Epidemiologic patterns of Hodgkin's disease. Int J Cancer 1971; 8: 192-201.
14. Harris NL. The many faces of Hodgkin's disease around the world: What have we learned from its pathology? Ann Oncol 1998; 9 (Suppl 5): S45-56.
15. Liu SM, Chow KC, Chiu CF, Tzeng CH. Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan. Cancer 1998; 83: 367-71.
16. Pan CC, Chen PC, Chiang H. An easy method for manual construction of high-density tissue arrays. Appl Immunohistochem Mol Morph 2004; 12: 370-2.
17. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours. Lyon: IARC Press, 2001.
18. Tsai ST, Jin YT, Wu TC. Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells. J Virol Meth 1995; 54: 67-74.
19. Gulley ML, Glaser SL, Craig FE et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol 2002; 117: 259-67.
20. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004; 125: 267-81.
21. Jarrett RF, Gallagher A, Jones DB et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age. J Clin Pathol 1991; 44: 844-8.
22. Lin JD, Chao TC, Sun JH, Ho C, Weng HF. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Oncology 2000; 58: 280-5.
23. Wang SM, Liu CC, Huang YS, Yang YJ, Lei HY. Change in hepatitis A virus seroepidemiology in southern Taiwan: A large percentage of the population lack protective antibody. J Med Virol 2001; 64: 104-8.
24. Takeuchi K, Morishita Y, Fukayama M, Mori S. Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: Trend between 1955 and 1999. Br J Haematol 2001; 113: 429-31.
25. Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P. The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001; 60: 289-302.
26. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328-37.
27. Asso-Bonnet M, Feuillard J, Ferreira V et al. Relationship between IκBα constitutive expression, TNFα synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene 1998; 17: 1607-15.
28. Devergne O, Hatzivassiliou E, Izumi KM et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation. Mol Cell Biol 1996; 16: 7098-108.
29. Thorley-Lawson DA. Epstein-Barr virus: Exploiting the immune system. Nat Rev Immunol 2001; 1: 75-82.
30. Bargou RC, Leng C, Krappmann D et al. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340-7.
31. Jarrett RF, Stark GL, White J et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 2005; 106: 2444-51.
32. Fellbaum C, Hansmann ML, Niedermeyer H et al. Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 1992; 98: 319-23.
33. Quinones-Avila Mdel P, Gonzalez-Longoria AA, Admirand JH, Medeiros LJ. Hodgkin lymphoma involving Waldeyer ring: A clinicopathologic study of 22 cases. Am J Clin Pathol 2005; 123: 651-6.